RAPT RAPT THERAPEUTICS INC Expansion Plans 8-K Filing 2024 - License Agreement RAPT Therapeutics announced a license agreement with Shanghai Jemincare Pharmaceutical and a $150 million private placement on December 23, 2024.Get access to all SEC 8-K filings of the RAPT THERAPEUTICS INC